AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16919573 — intervention group
Group type: EXPERIMENTAL
Intervention: Poststress ESV index of 27 mL/m2 or less
Number of subjects: 6713
Study 16249982 — intervention group
Group type: EXPERIMENTAL
Intervention: Acustimulation using a portable transcutaneous electrical nerve stimulation device (Reliefband) attached 15 minutes before the procedure, turned on in 78 patients (Group 1)
Number of subjects: 327
Study 16249982 — intervention group
Group type: COMPARATOR
Intervention: Device attached but not turned on (Group 2)
Number of subjects: 327
Study 16249982 — intervention group
Group type: COMPARATOR
Intervention: Device attached to the Sham point (Group 3)
Number of subjects: 327
Study 16249982 — intervention group
Group type: COMPARATOR
Intervention: No attachments (Group 4)
Number of subjects: 327
Study 11156644 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin (BT) injection (20 U) and subsequent daily applications of isosorbide dinitrate (ID) (2.5 mg three times daily for three months)
Number of subjects: 30
Study 11156644 — intervention group
Group type: COMPARATOR
Intervention: Botulinum toxin (BT) injection only (20 U)
Number of subjects: 30
Study 9736895 — intervention group
Group type: EXPERIMENTAL
Intervention: Examinations conducted by trained therapists
Number of subjects: 138
Study 9736895 — intervention group
Group type: COMPARATOR
Intervention: Therapists trained in examination techniques
Number of subjects: 138
Study 7507304 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprotinin (2 x 10(6) KIU bolus followed by 5 x 10(5) KIU/h infusion until end of surgery
Number of subjects: 40
Study 7507304 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 40
Study 2895173 — intervention group
Group type: EXPERIMENTAL
Intervention: Early hypocaloric enteral feeding (PO)
Number of subjects: 19
Study 31597670 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic sexual health module with tailored feedback (randomized for half of the participants)
Number of subjects: 66
Study 31597670 — intervention group
Group type: COMPARATOR
Intervention: Electronic sexual health module without tailored feedback
Number of subjects: 66
Study 28667231 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational video about OSA and CPAP therapy
Number of subjects: 212
Study 28667231 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 212
Study 26090880 — intervention group
Group type: EXPERIMENTAL
Intervention: Compressive stockings
Number of subjects: 40
Study 26090880 — intervention group
Group type: COMPARATOR
Intervention: Placebo stockings
Number of subjects: 40
Study 23898909 — intervention group
Group type: COMPARATOR
Intervention: SSRIs
Number of subjects: 30
Study 23898909 — intervention group
Group type: COMPARATOR
Intervention: SSRIs plus quetiapine
Number of subjects: 30
Study 21999887 — intervention group
Group type: EXPERIMENTAL
Intervention: SQ-standardized grass allergy immunotherapy tablet (AIT)
Number of subjects: 812
Study 21999887 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 812
Study 20178207 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamide peroxide treatment for 14 days
Number of subjects: 24
Study 20178207 — intervention group
Group type: COMPARATOR
Intervention: Artificial saliva (control)
Number of subjects: 24
Study 16774090 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycling training group (N=10)
Number of subjects: 24
Study 16774090 — intervention group
Group type: COMPARATOR
Intervention: Control group (N=14)
Number of subjects: 24
Study 15501704 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium and Vitamin D supplementation
Number of subjects: 120
Study 15501704 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 10938220 — intervention group
Group type: EXPERIMENTAL
Intervention: behavioral counseling
Number of subjects: 505
Study 10938220 — intervention group
Group type: COMPARATOR
Intervention: standard health promotion
Number of subjects: 505
Study 9293346 — intervention group
Group type: COMPARATOR
Intervention: Treadmill training (TM; N = 8)
Number of subjects: 26
Study 9293346 — intervention group
Group type: COMPARATOR
Intervention: Cycle ergometer training (CY; N = 10)
Number of subjects: 26
Study 8337172 — intervention group
Group type: EXPERIMENTAL
Intervention: CSG with coaching
Number of subjects: 64
Study 8337172 — intervention group
Group type: COMPARATOR
Intervention: CSG without coaching
Number of subjects: 64
Study 8337172 — intervention group
Group type: COMPARATOR
Intervention: No CSG
Number of subjects: 64
Study 2440199 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethinyl estradiol sulfonate (Turisteron)
Number of subjects: 0
Study 2440199 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 0
Study 27798291 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily meal delivery (n = 139)
Number of subjects: 371
Study 27798291 — intervention group
Group type: EXPERIMENTAL
Intervention: Once weekly, frozen meal delivery (n = 106)
Number of subjects: 371
Study 27798291 — intervention group
Group type: COMPARATOR
Intervention: Control group (waiting list, n = 126)
Number of subjects: 371
Study 27648674 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-bundle (DB) technique
Number of subjects: 50
Study 27648674 — intervention group
Group type: COMPARATOR
Intervention: Single-bundle (SB) technique
Number of subjects: 50
Study 24725445 — intervention group
Group type: EXPERIMENTAL
Intervention: Test product (300 mg irbesartan tablet)
Number of subjects: 26
Study 24725445 — intervention group
Group type: COMPARATOR
Intervention: Reference product (300 mg irbesartan tablet)
Number of subjects: 26
Study 23734218 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid (FA) 0.8 mg / B12 0.4 mg with and without 40 mg B6
Number of subjects: 183
Study 23734218 — intervention group
Group type: EXPERIMENTAL
Intervention: B6 alone
Number of subjects: 183
Study 23734218 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 183
Study 20091404 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 143
Study 20091404 — intervention group
Group type: COMPARATOR
Intervention: Active control
Number of subjects: 143
Study 20091404 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 143
Study 18823190 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental introduction to counseling program
Number of subjects: 400
Study 18823190 — intervention group
Group type: COMPARATOR
Intervention: Standard-introduction to counseling program
Number of subjects: 400
Study 18823190 — intervention group
Group type: COMPARATOR
Intervention: Information-control group
Number of subjects: 400
Study 18823190 — intervention group
Group type: COMPARATOR
Intervention: No-information-control group
Number of subjects: 400
Study 16177808 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg THC
Number of subjects: 19
Study 16177808 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 15052277 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity (HI) exercise (three times 30 min in an interval protocol (2.5 min 80/50% W(max)))
Number of subjects: 8
Study 15052277 — intervention group
Group type: COMPARATOR
Intervention: Low-Intensity (LI) exercise (three times 60 min continuously at 38% W(max))
Number of subjects: 8
Study 15052277 — intervention group
Group type: EXPERIMENTAL
Intervention: Both HI and LI exercise protocols
Number of subjects: 8
Study 10904461 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking program targeted to expend 4.2 MJ/wk and diet counseling (walk-1 group)
Number of subjects: 82
Study 10904461 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking program of 8.4 MJ/wk and diet counseling (walk-2 group)
Number of subjects: 82
Study 10904461 — intervention group
Group type: COMPARATOR
Intervention: Control group with no increase in habitual exercise and counseling on diet and relapse prevention
Number of subjects: 82
Study 9291340 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenidap (120 mg) daily for 6 weeks
Number of subjects: 43
Study 9291340 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 7686709 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP) 30 mg/kg i.v.
Number of subjects: 21
Study 7686709 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline (control group)
Number of subjects: 21
Study 2874983 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 2874983 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentobarbital
Number of subjects: 12
Study 2874983 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbromal
Number of subjects: 12
Study 2874983 — intervention group
Group type: EXPERIMENTAL
Intervention: Methaqualone
Number of subjects: 12
Study 2874983 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunitrazepam
Number of subjects: 12
Study 2874983 — intervention group
Group type: EXPERIMENTAL
Intervention: Lormetazepam
Number of subjects: 12
Study 2874983 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam
Number of subjects: 12
Study 31821654 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based physiotherapy (n = 24)
Number of subjects: 50
Study 31821654 — intervention group
Group type: COMPARATOR
Intervention: Standard care (n = 26)
Number of subjects: 50
Study 31821654 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Group-based physiotherapy and Standard care)
Number of subjects: 50
Study 30583933 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized lifestyle intervention group (LIG)
Number of subjects: 799
Study 30583933 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 799
Study 28458123 — intervention group
Group type: EXPERIMENTAL
Intervention: Caseload midwifery
Number of subjects: 1748
Study 28458123 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1748
Study 25382740 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistive vibration exercise
Number of subjects: 24
Study 25382740 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise without vibration
Number of subjects: 24
Study 25382740 — intervention group
Group type: COMPARATOR
Intervention: No exercise (control group)
Number of subjects: 24
Study 24004640 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive Reappraisal Coping Intervention (PRCI)
Number of subjects: 372
Study 24004640 — intervention group
Group type: COMPARATOR
Intervention: PRCI Control group
Number of subjects: 372
Study 20977390 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice (BR)
Number of subjects: 10
Study 20977390 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugar-sweetened fruit drink (SSD)
Number of subjects: 10
Study 20977390 — intervention group
Group type: COMPARATOR
Intervention: Orange juice
Number of subjects: 10
Study 20977390 — intervention group
Group type: COMPARATOR
Intervention: Spaghetti
Number of subjects: 10
Study 19060453 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 weeks of training
Number of subjects: 13
Study 19060453 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 weeks of detraining
Number of subjects: 13
Study 19060453 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 weeks of retraining
Number of subjects: 13
Study 19060453 — intervention group
Group type: COMPARATOR
Intervention: Detraining
Number of subjects: 13
Study 19060453 — intervention group
Group type: COMPARATOR
Intervention: Retraining
Number of subjects: 13
Study 17103487 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg DiaPep277
Number of subjects: 99
Study 17103487 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 mg DiaPep277
Number of subjects: 99
Study 17103487 — intervention group
Group type: COMPARATOR
Intervention: 2.5 mg DiaPep277
Number of subjects: 99
Study 17103487 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 14699544 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic proximal segment positioning by intraoperative sonography
Number of subjects: 30
Study 14699544 — intervention group
Group type: COMPARATOR
Intervention: Splint and plate positioning
Number of subjects: 30
Study 11706697 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate drain opening (n = 45)
Number of subjects: 76
Study 11706697 — intervention group
Group type: COMPARATOR
Intervention: Drains opened at 2 h (n = 31)
Number of subjects: 76
Study 9371164 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic amiodarone
Number of subjects: 6553
Study 8485271 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisapride 10 mg q.d.s. for 12 weeks
Number of subjects: 48
Study 8485271 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 3333512 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic cloxacillin
Number of subjects: 100
Study 3333512 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 30892290 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided bone regeneration with dental implant placement (study group)
Number of subjects: 22
Study 30892290 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 22
Study 27737534 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine/Cisplatin (GP) - Gemcitabine 1,250 mg/m2 on days 1 and 8, Cisplatin 75 mg/m2 on day 1 every 3 weeks
Number of subjects: 279
Study 27737534 — intervention group
Group type: COMPARATOR
Intervention: Irinotecan/Cisplatin (IP) - Irinotecan 65 mg/m2 and Cisplatin 30 mg/m2 on days 1 and 8 every 3 weeks
Number of subjects: 279
Study 24671388 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (1.0 mg/kg in 20 ml of normal saline)
Number of subjects: 60
Study 24671388 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine-levobupivacaine (0.5 mg/kg of ketamine plus 50.0 mg of 0.25% levobupivacaine in 20 ml of normal saline)
Number of subjects: 60
Study 24671388 — intervention group
Group type: COMPARATOR
Intervention: Control (20 ml of intraarticular normal saline)
Number of subjects: 60
Study 22688605 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation in obese participants before weight loss
Number of subjects: 31
Study 22688605 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation in obese participants after weight loss
Number of subjects: 31
Study 22688605 — intervention group
Group type: COMPARATOR
Intervention: Electrical stimulation in nonobese participants
Number of subjects: 31
Study 21777715 — intervention group
Group type: EXPERIMENTAL
Intervention: Armodafinil (250 mg/d)
Number of subjects: 70
Study 21777715 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 19734382 — intervention group
Group type: EXPERIMENTAL
Intervention: True acupuncture
Number of subjects: 41
Study 19734382 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 41
Study 16449110 — intervention group
Group type: EXPERIMENTAL
Intervention: Heated, 95% humidified CO2
Number of subjects: 89
Study 16449110 — intervention group
Group type: COMPARATOR
Intervention: Heated, dry CO2
Number of subjects: 89
Study 12509398 — intervention group
Group type: EXPERIMENTAL
Intervention: CEE+MPA-cyclic (daily CEE and MPA at 10 mg/day on days 1-12)
Number of subjects: 571
Study 12509398 — intervention group
Group type: EXPERIMENTAL
Intervention: CEE+MPA-continuous (daily CEE and MPA at 2.5 mg/day)
Number of subjects: 571
Study 12509398 — intervention group
Group type: EXPERIMENTAL
Intervention: CEE-MP (daily CEE and micronized progesterone at 200 mg/day on days 1-12)
Number of subjects: 571
Study 12509398 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 571
Study 11025235 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1) administered intravenously at up to 15 ng/kg/min for 72 hours after surgery
Number of subjects: 39
Study 11025235 — intervention group
Group type: COMPARATOR
Intervention: Placebo (isotonic saline) administered for the same duration
Number of subjects: 39
Study 11025235 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1)
Number of subjects: 39
Study 11025235 — intervention group
Group type: COMPARATOR
Intervention: Placebo (isotonic saline)
Number of subjects: 39
Study 8658340 — intervention group
Group type: EXPERIMENTAL
Intervention: Various treatments for eyelid dermatitis (specific treatments not detailed in the abstract)
Number of subjects: 0
Study 1609246 — intervention group
Group type: EXPERIMENTAL
Intervention: Terodiline
Number of subjects: 0
Study 1609246 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 4096071 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous streptokinase (IV)
Number of subjects: 200
Study 4096071 — intervention group
Group type: COMPARATOR
Intervention: Intracoronary streptokinase (IC)
Number of subjects: 200
Study 31737686 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic Training (AT)
Number of subjects: 105
Study 31737686 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 105
Study 31737686 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 105
Study 29772291 — intervention group
Group type: EXPERIMENTAL
Intervention: Watching television while exercising
Number of subjects: 24
Study 29772291 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to music while exercising
Number of subjects: 24
Study 29772291 — intervention group
Group type: COMPARATOR
Intervention: Exercising with no other stimulus (control)
Number of subjects: 24
Study 27411777 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) plus normal saline (NS)
Number of subjects: 257
Study 27411777 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (NaHCO3) plus normal saline (NS)
Number of subjects: 257
Study 27411777 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (NS) alone
Number of subjects: 257
Study 24067260 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg/d THC
Number of subjects: 11
Study 24067260 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg/d THC
Number of subjects: 11
Study 24067260 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 mg/d THC
Number of subjects: 11
Study 24067260 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0 mg/d THC)
Number of subjects: 11
Study 23059145 — intervention group
Group type: EXPERIMENTAL
Intervention: d‐cycloserine (50 mg)
Number of subjects: 20
Study 23059145 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 20613539 — intervention group
Group type: EXPERIMENTAL
Intervention: Peritonsillar lornoxicam infiltration
Number of subjects: 60
Study 20613539 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lornoxicam
Number of subjects: 60
Study 20613539 — intervention group
Group type: COMPARATOR
Intervention: Control (i.v. and peritonsillar saline infiltration)
Number of subjects: 60
Study 18410644 — intervention group
Group type: EXPERIMENTAL
Intervention: Incredible Years (IY) BASIC Parenting Programme
Number of subjects: 50
Study 18410644 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 50
Study 16025322 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine/naloxone 2/0.5 mg
Number of subjects: 7
Study 16025322 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine/naloxone 8/2 mg
Number of subjects: 7
Study 16025322 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine/naloxone 32/8 mg
Number of subjects: 7
Study 16025322 — intervention group
Group type: COMPARATOR
Intervention: Control group (recently detoxified participants, N=8)
Number of subjects: 7
Study 16025322 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine/naloxone (all doses)
Number of subjects: 7
Study 12411797 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 51
Study 12411797 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 51
Study 10499753 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 0.5 microg/kg intramuscularly and saline in the surgical site
Number of subjects: 45
Study 10499753 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 0.5 microg/kg in the surgical site and saline intramuscularly
Number of subjects: 45
Study 10499753 — intervention group
Group type: COMPARATOR
Intervention: Saline in both the surgical site and intramuscularly (Control)
Number of subjects: 45
Study 8891659 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory-guided saccade task in schizophrenic patients
Number of subjects: 30
Study 8891659 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed-saccade task in schizophrenic patients
Number of subjects: 30
Study 8891659 — intervention group
Group type: COMPARATOR
Intervention: Memory-guided saccade task in normal controls
Number of subjects: 30
Study 8891659 — intervention group
Group type: COMPARATOR
Intervention: Delayed-saccade task in normal controls
Number of subjects: 30
Study 8891659 — intervention group
Group type: EXPERIMENTAL
Intervention: Final eye position after correction saccades in both groups
Number of subjects: 30
Study 1502490 — intervention group
Group type: EXPERIMENTAL
Intervention: Bismuth subsalicylate (Pepto-Bismol) - 2 tablets four times daily for 4 weeks
Number of subjects: 18
Study 1502490 — intervention group
Group type: EXPERIMENTAL
Intervention: Bismuth subsalicylate combined with clindamycin - 2 weeks of 300 mg clindamycin four times daily
Number of subjects: 18
Study 6497564 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol (5 mg test dose; 10 mg maintenance dose)
Number of subjects: 100
Study 6497564 — intervention group
Group type: COMPARATOR
Intervention: Thiothixene hydrochloride (0.22 mg/kg test dose; 0.44 mg/kg maintenance dose)
Number of subjects: 100
Study 6497564 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol (5 mg test dose)
Number of subjects: 100
Study 6497564 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 100
Study 31586371 — intervention group
Group type: EXPERIMENTAL
Intervention: NASM exercises with ergonomic intervention (12 weeks)
Number of subjects: 23
Study 31586371 — intervention group
Group type: COMPARATOR
Intervention: Control group (no regular exercise)
Number of subjects: 23
Study 29929990 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular advancement device
Number of subjects: 27
Study 29929990 — intervention group
Group type: COMPARATOR
Intervention: Sham device
Number of subjects: 27